There's a big difference between commodity chemical companies and specialty chemical companies - both can make you money, but companies with more of a commodity orientation have to be sold more nimbly. That's not to say, however, that investors can just buy a company like Albemarle (NYSE:ALB) whenever they may like. While this is a very interesting and well-run chemical company, today's valuation doesn't offer much discount despite multiple challenges to the business.

Investopedia Broker Guide: Enhance your trading with the tools from today's top online brokers.

Three Companies In One
Albemarle is essentially three chemical companies in one, as the company gets broadly-equal contributions to revenue from its polymer solutions, catalyst and fine chemical operations. In polymer solutions, flame retardants (particularly bromine-based products) are the dominant contributor to results, though the company also sells various curatives, antioxidants and stabilizers. The catalyst business is largely focused on catalysts needed in refining oil and various organometallics. Last but not least, fine chemicals is built around various bromine products, as well as products for agriculture, pharmaceuticals and the energy markets.

Strong Share And Visible Competition
At least part of Albemarle's success can be tied to its strong share in many markets. Bromine supply is very nearly a triopoly with Chemtura (NYSE:CHMT) and Israel Chemicals (OTC:ISCHY), and the company likewise has significant share in categories like bromine-based fire retardants and bromine products used in consumer electronics.

Albemarle also owns significant share in the refinery catalyst market, with Royal Dutch Shell (NSYE:RDS.A), W.R. Grace (NYSE:GRA) and BASF (OTC:BASFY) standing as its largest rivals. Although the company holds less share and faces a more diverse group of competitors in the fine chemicals operations, it is nonetheless a leading producer of both ibuprofen and fluids used in energy exploration.

SEE: Economics Basics: Monopolies, Oligopolies And Perfect Competition

Changing Markets Will Give, And Take, Opportunities
On the positive side of the ledger, Albemarle should be able to look forward to more and more heavy oil usage in the refining process, and heavy oil refining typically requires more (and/or more expensive) catalysts. At the same time, tighter air quality standards could increase the demand for Albemarle chemicals in utility scrubbers.

It would also appear that Albemarle has meaningful opportunities in agriculture and technology. The company's organometallics technologies should make it a significant part of the supply chain for future LED, LCD and AMOLED production. On the agriculture side, an active urease inhibitor product (NBPT) has shown promise as a way to reduce the breakdown of nitrogen-bearing fertilizers in the soil, allowing farmers to use less fertilizer without compromising yields.

But it's not as though the company does not have challenges. Bromine seems to have been in something of a "supercycle" for several years and it's worth asking if the company can continue to maintain past margins. What's more, many consumer electronics companies are phasing bromine out of their products - Apple (Nasdaq:AAPL) was arguably the leader in going bromine-free, but Hewlett-Packard (NYSE:HPQ), Dell (Nasdaq:DELL), Lenovo (OTC:LNVGY) and Samsung have all made commitments to significantly reduce bromine content in their products as well. With electronics representing about 15% of Albemarle's end-market demand, that's not a trivial risk.

Closer to today, the company is also seeing some challenges from the macroeconomic environment. Inventory de-stocking in flame retardants and weak consumer electronics demand have both helped to push down expectations for second half profits. Thinking more broadly, while Albemarle may be better-positioned than commodity chemical companies and has indeed generated strong returns for a while, the company still needs a healthy global economy to do well.

SEE: Explaining The World Through Macroeconomic Analysis

The Bottom Line
Unlike so many chemical companies, Albemarle not only generates good cash flow, it does so on a pretty consistent basis. Assuming that the global economy doesn't really slip over the next year, there's a pretty good chance that Albemarle will be in a net-cash position by the end of 2013, giving the company the option to either acquire more businesses or buy back stock.

With a solid platform of value-added products, I clearly like Albemarle. I cannot say the same for the stock, at least not without some reservations. A discounted cash flow and forward EV/EBITDA both point to fair value in the high $50s. What's more, Albemarle has pretty consistently traded at an average trailing EV/EBTIDA of 8.5 times; comparing that to today's multiple suggests a target price in the low $60s. As a result, while Albemarle is certainly the type of company I'd like to own, I'd need to see more of a pullback in the shares before adding it to my own portfolio.

At the time of writing, Stephen D. Simpson did not own any shares in any company mentioned in this article.

Related Articles
  1. Stock Analysis

    How Toyota Succeeds at Home and Abroad (TM)

    Japan's biggest car manufacturer is also one of North America's biggest, delighting shareholders with its high profit margins.
  2. Stock Analysis

    Starbucks: Profiting One Cup at a Time (SBUX)

    Starbucks is everywhere. But is it a worthwhile business? Ask the shareholders who've made it one of the world's most successful companies.
  3. Stock Analysis

    How Medtronic Makes Money (MDT)

    Here's the story of an American medical device firm that covers almost every segment in medicine and recently moved to Ireland to pay less in taxes.
  4. Investing News

    Latest Labor Numbers: Good News for the Market?

    Some economic numbers are indicating that the labor market is outperforming the stock market. Should investors be bullish?
  5. Investing News

    Stocks with Big Dividend Yields: 'It's a Trap!'

    Should you seek high yielding-dividend stocks in the current investment environment?
  6. Investing News

    Should You Be Betting with Buffett Right Now?

    Following Warren Buffett's stock picks has historically been a good strategy. Is considering his biggest holdings in 2016 a good idea?
  7. Products and Investments

    Cash vs. Stocks: How to Decide Which is Best

    Is it better to keep your money in cash or is a down market a good time to buy stocks at a lower cost?
  8. Investing News

    Who Does Cheap Oil Benefit? See This Stock (DG)

    Cheap oil won't benefit most companies, but this retailer might buck that trend.
  9. Investing

    How to Ballast a Portfolio with Bonds

    If January and early February performance is any guide, there’s a new normal in financial markets today: Heightened volatility.
  10. Stock Analysis

    Performance Review: Emerging Markets Equities in 2015

    Find out why emerging markets struggled in 2015 and why a half-decade long trend of poor returns is proving optimistic growth investors wrong.
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
Trading Center